Ligand-specific regulation of proteasome-mediated proteolysis of estrogen receptor-α

American Journal of Physiology - Endocrinology and Metabolism

Volumn 282, Issue 4 45-4, 2002, Pages

  Preisler Mashek, Mara T ^a   Solodin, Natalia ^a   Stark, Bethany L ^a   Tyriver, Michael K ^a   Alarid, Elaine T ^a  

^a Dept of Pathol and Lab Medicine 505 Service Memorial Institute   (United States)

Author keywords

Antagonist; Estriol; Nuclear receptor; Pituitary; Steroid

Indexed keywords

17ALPHA ESTRADIOL; CELL NUCLEUS RECEPTOR; ESTRIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; PROTEASOME; STEROID;

ARTICLE; BINDING AFFINITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; HYPOPHYSIS; LIGAND BINDING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM;

EID: 0036080310     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00353.2001     Document Type: Article

References (45)

1. Proteasome-mediated proteolysis of estrogen receptors: A novel component in autologous down-regulation
2. Estrogen-induced uterine responses and growth: Relationship to receptor estrogen binding by uterine nuclei
3. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression
4. Estrogenic and anti-estrogenic regulation of half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Molecular basis of agonism and antagonism in the oestrogen receptor
7. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth
8. Nuclear binding and retention of the receptor estrogen complex; relation to the agonist and antagonistic properties of estriol
9. Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors
10. Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover
11. Biochemical and ultrastructural studies on estrogeninduced pituitary tumors in F344 rats
12. Identification of amino acids in the hormone binding domain of the human estrogen receptor important in estrogen binding
13. Antisera to a synthetic peptide recognize native and denatured rat estrogen receptors
14. The mechanism of ICI 164,384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue
15. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells
16. Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation
17. Comparative effectiveness of oestrogens on fluid imbibation and growth of the rat's uterus
18. Nuclear mechanism of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing
19. NF-κB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events
20. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation
21. Implication of proteasome in estrogen receptor degradation
22. Up-regulation of estrogen receptors by nonsteroidal antiestrogens in human breast cancer
23. Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
24. The 26S proteasome is required for estrogen receptor-α and coactivator turnover and for efficient estrogen receptor-α transactivation
25. Molecular and kinetic basis for the mixed agonist/antagonist activity of estriol
26. Novel IκBα proteolytic pathway in WEHI 231 immature B cells
27. Characterization of the estrogen receptor and its dynamics in MCF-7 human breast cancer cells using a covalently attaching antiestrogen
28. Proteasome-dependent degradation of the human estrogen receptor
29. 9-cis-retinoic acid decreases the level of its cognate receptor, retinoic X receptor, through acceleration of the turnover
30. Reduction in the expression and action of transforming growth factor β1 on lactotropes during estrogen-induced tumorigenesis in the anterior pituitary
31. Structural aspects of agonism and antagonism in the oestrogen receptor
32. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines
33. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors
34. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen
35. Autologous down-regulation of messenger ribonucleic acid and protein levels for estrogen receptors in MCF-7 cells: An inverse correlation to progesterone receptors
36. Regulation of the estrogen receptor in MCF-7 cells by estradiol
37. Role of estrogen receptor-α in the anterior pituitary gland
38. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
39. Subnuclear trafficking of estrogen receptor-α and steroid receptor coactivator-1
40. FRAP reveals that mobility of oestrogen receptor-α is ligand- and proteasome-dependent
41. Evidence for enhanced ubiquitin-mediated proteolysis of the chicken progesterone receptor
42. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
43. Stable and specific binding of heat shock protein 90 by geldanamycin disrupts glucocorticoid receptor function in intact cells
44. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats
45. Retinoic acid induces proteasome-dependent degradation of retinoic acid reeptor α (RARα) and oncogenic RARα fusion proteins